Bridgewater Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bridgewater Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$461K	Sell	7,286 -2	-0%	-$115	0.03%	293
2026 Q1	$402K	Buy	7,288 +126	+2%	+$7.34K	0.02%	304
2025 Q4	$390K	Buy	7,162 +325	+5%	+$15.6K	0.03%	311
2025 Q3	$319K	Buy	6,837 +99	+1%	+$4.62K	0.02%	333
2025 Q2	$316K	Sell	6,738 -1,230	-15%	-$60.4K	0.02%	327
2025 Q1	$392K	Buy	+7,968	New	+$464K	0.03%	274
2023 Q2	–	Sell	-10,204	Closed	-$707K	–	107
2023 Q1	$707K	Sell	10,204 -183	-2%	-$12.9K	0.15%	85
2022 Q4	$747K	Sell	10,387 -5,816	-36%	-$439K	0.18%	85
2022 Q3	$1.15M	Buy	16,203 +5,984	+59%	+$434K	0.32%	63
2022 Q2	$787K	Sell	10,219 -4,373	-30%	-$333K	0.16%	97
2022 Q1	$1.07M	Buy	14,592 +230	+2%	+$15.4K	0.26%	83
2021 Q4	$895K	Buy	14,362 +156	+1%	+$9.15K	0.2%	104
2021 Q3	$841K	Sell	14,206 -18,769	-57%	-$1.24M	0.23%	97
2021 Q2	$2.2M	Buy	32,975 +10,785	+49%	+$703K	0.7%	37
2021 Q1	$1.43M	Buy	+22,190	New	+$1.38M	0.73%	41

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bridgewater Advisors's BMY Position: Q2 2026 in Review

Bridgewater Advisors reduced its Bristol-Myers Squibb (BMY) stake by 0.03% in Q2 2026, selling an estimated $115 and leaving 7,286 shares worth $461K. The position accounts for 0.03% of the portfolio, ranked #293.

Bridgewater Advisors first reported a position in BMY in Q1 2021 and has held it in 15 quarters since. The position peaked at $2.2M in Q2 2021. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Bridgewater Advisors held 7,286 shares of Bristol-Myers Squibb worth $461K as of Q2 2026.
Bridgewater Advisors sold 2 Bristol-Myers Squibb shares in Q2 2026, an estimated $115.
Bristol-Myers Squibb made up 0.03% of Bridgewater Advisors's portfolio in Q2 2026, its #293 holding.
Bridgewater Advisors first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 15 quarters since.
Bridgewater Advisors's Bristol-Myers Squibb position peaked at $2.2M in Q2 2021.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Bridgewater Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.